Oxtellar XR (oxcarbazepine) NDC 17772-123

NDC codes

FDA NDC Directory

Product NDC (as listed)17772-123Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17772-0123Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
17772-123-01	17772012301	100 TABLET in 1 BOTTLE (17772-123-01)Marketed from Jan 17, 2013
17772-123-07	17772012307	7 TABLET in 1 BOTTLE (17772-123-07)Marketed from Jul 1, 2023 · Sample package
17772-123-10	17772012310	5 TABLET in 1 BLISTER PACK (17772-123-10)Marketed from Jan 17, 2013 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxtellar XR
Generic name (nonproprietary): oxcarbazepine
Active ingredients: Oxcarbazepine — 600 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Supernus Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 202810
Marketing start: Jan 17, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 17772-123_5b887c21-e4f8-1936-e063-6294a90a6db7SPL ID 5b887c21-e4f8-1936-e063-6294a90a6db7
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417772012301 followed by a unit qualifier and the quantity

Package 17772-0123-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under NDA 202810

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 202810
Product	Strength	Form · route	Labeler	Product NDC
Oxtellar XRoxcarbazepine	Oxcarbazepine 300 mg/1	TabletOral	Supernus Pharmaceuticals, Inc.	17772-122
Oxtellar XRoxcarbazepine	Oxcarbazepine 150 mg/1	TabletOral	Supernus Pharmaceuticals, Inc.	17772-121